Is Ibrutinib-related Atrial Fibrillation Dose Dependent

Clinical trial NCT06224452 · UNKNOWN

Trial details

NCT number: NCT06224452
Sponsor: University Hospital, Caen
Status: UNKNOWN
Study type: OBSERVATIONAL

Hematological Malignancy Atrial Fibrillation

Start date: 2024-03-01
Primary completion: 2024-05-01
Enrollment: 18000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.